Call in to speak with the host
MONDAY, June 25, 2012 - 3:30 pm PST/6:30 pm EST
Tonight - an update from our amazing Huntington Study Group (HSG) Reach2HD clinical trial Principal Investigator (PI) Dr. Ray Dorsey and Dr. Caroline Herd, Chief Development Consultant from Prana Biotechnology.
Reach2HD is a study to discover whether PBT2 (an investigational drug) is safe and effective and to determine PBT2's effect on cognition (thinking abilities) and other symptoms including movement and overall functioning.
Tune in for a very informative update on Reach2HD another Huntington Study Group clinical trial.
Sorry we couldn't complete your registration. Please try again.
Please enter your email to finish creating your account.
old-style code for hosted blogs
300 x 295
400 x 370
640 x 550
Receive a personalized list of podcasts based on your preferences.